Inspire Medical Systems Sets Date for Q3 Financial Results
Inspire Medical Systems, Inc. (NYSE: INSP) is gearing up to announce its financial results for the third quarter of 2024. The results will be made available after the trading day wraps up on November 4, 2024. This is a significant moment for the company as it showcases their progress and achievements over the past quarter.
Conference Call Details
Following the release of the financial results, Inspire's management will conduct a conference call at 5:00 p.m. Eastern Time. This call serves as an opportunity for the management team to delve into the financial figures and share insights regarding recent business developments. Investors and interested parties are encouraged to tune in and gain comprehensive knowledge of Inspire's current standing.
Accessing the Live Webcast
For those wishing to listen to the call, a webcast will be available on Inspire's Investor Relations page. This platform is designed to enhance accessibility for investors. It's important for participants, especially those who have questions, to make use of this opportunity to engage with the company's leadership.
Question Participation
Investors interested in asking questions during the call should ensure they register beforehand. An email confirmation will provide attendees with dial-in details and a unique access code necessary for participation. Inspire encourages everyone to register at least 10 minutes before the event to ensure a smooth connection.
Post-Call Replay Availability
For those unable to join the call live, Inspire will offer a replay on its Investor Relations website about two hours after the call concludes. This replay will remain accessible for two weeks, allowing stakeholders a chance to revisit the discussed topics and insights shared by the management.
Overview of Inspire Medical Systems
Inspire Medical Systems focuses on creating innovative and minimally invasive solutions aimed at treating obstructive sleep apnea. Their flagship product, Inspire therapy, holds a unique position as the first and only neurostimulation technology approved by regulatory bodies such as the FDA, EU MDR, and PDMA. This revolutionary therapy provides patients with a safe and effective treatment option for managing moderate to severe obstructive sleep apnea.
Company Values and Vision
At the core of Inspire's mission is the commitment to improving patient outcomes through advanced medical technology. The company is dedicated to ensuring that individuals battling obstructive sleep apnea experience a significant enhancement in their quality of life, showcasing the profound impact that innovative solutions can have on everyday living.
Investor and Media Relations
As part of their outreach, Inspire Medical Systems encourages communication with investors and media contacts. Ezgi Yagci, the Vice President of Investor Relations, is available for queries via email or phone. This open line of communication helps maintain transparency and fosters trust with their investors and stakeholders.
Frequently Asked Questions
What date is Inspire Medical Systems announcing its Q3 financial results?
Inspire will announce its Q3 financial results on November 4, 2024.
How can I participate in the Q3 conference call?
You can register for the call to ask questions or listen via the webcast on the Investor Relations page of Inspire's website.
Is there a replay available for the conference call?
Yes, a replay will be available two hours after the call and will be archived for two weeks on Inspire's website.
What does Inspire Medical Systems specialize in?
Inspire Medical Systems specializes in innovative treatments for obstructive sleep apnea, particularly with their proprietary Inspire therapy.
How can I contact Inspire Medical Systems for investor inquiries?
You can reach out to Ezgi Yagci, the Vice President of Investor Relations, via email or phone for any investor-related inquiries.
